illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. 10X Genomics
Company logo

10X Genomics | Sustainability Performance

https://www.10xgenomics.com
Linkedin

Develops single cell and spatial biology instruments, consumables and software for life science research.

2012

United States

1,001 - 5,000 employees

Biotechnology

$500M - 1B in revenue

N/A in profitability

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#3905
Overall
#798
in United States
#52
in Biotechnology

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

59 out of 251

Overview
Governance
TargetsESG scores and exclusions
Financial Data
Business performanceCapital & innovation

View similiar companies


Company logo
Envista

United States, Hospital & Health Care, Medical Device


Company logo
Encompass health

United States, Hospital & Health Care, Hospital & Health Care


Company logo
Biomarin Pharmaceutical

United States, Hospital & Health Care, Biotechnology

Market cap

8.5B $, 2026▲80.2% YoY

Revenue

642.8M $, 2026

R&D intensity

37.07% 2025

Market cap

8.5B $, 2026▲80.2% YoY

Revenue

642.8M $, FY2026▼NaN% YoY

EBITDA

-110.0M $, FY2025▼9.1% YoY

Operating margin

-17% Industry: -3538▼84.7% YoY

Revenue by region


Revenue by region %

Americas
Asia-Pacific
Europe, Middle East and Africa

Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

-6.7M 2024▼861.8% YoY

Capex

13.0M 2024▼276.9% YoY

Debt/equity ratio

0.0 Industry: 1▼NaN% YoY

R&D intensity

37.1%FY2025

R&D as % of revenue

R&D as % of revenue
Industry benchmark

Powered by illuminem

Return on invested capital

-5.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Not available

Recycling policy

Not available

Workplace health & safety policy

Not available

60%
Independent Directors

6 out of 10 incl. management

Powered by illuminem

Overall score

28

Environment

32

Social

19

Governance

33

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

Not reporting on Sustainability


image report
Available

Sustainability employees


    Available in
    Scale package

    Access
  • Email

  • Email